US regulators approve first digital pill to track patients

National
800 (2)_497855

WASHINGTON (AP) — U.S. regulators have approved the first drug with a sensor that alerts doctors when the medication has been taken, offering a new way of monitoring patients but also raising privacy concerns.

The digital pill approved Monday combines two existing products: the former blockbuster psychiatric medication Abilify — long used to treat schizophrenia and bipolar disorder — with a sensor tracking system first approved in 2012.

The technology is intended to help prevent dangerous emergencies that can occur when patients skip their medication, such as manic episodes experienced by those suffering from bipolar disorder.

But developers Otsuka Pharmaceutical Co. and Proteus Digital Health are likely to face hurdles. The pill has not yet been shown to actually improve patients’ medication compliance, a feature insurers are likely to insist on before paying for the pill. Additionally, patients must be willing to allow their doctors and caregivers to access the digital information.

These privacy issues are likely to crop up more often as drugmakers and medical device companies combine their products with technologies developed by Silicon Valley.

The new pill, Abilify MyCite, is embedded with a digital sensor that is activated by stomach fluids, sending a signal to a patch worn by the patient and notifying a digital smartphone app that the medication has been taken.

The FDA stressed however that there are limitations to monitoring patients.

“Abilify MyCite should not be used to track drug ingestion in ‘real-time’ or during an emergency,” the statement said, “because detection may be delayed or may not occur.”

Patients can track their dosage on their smartphone and allow their doctors, family or caregivers to access the information through a website.

In a statement issued last May at the time the FDA accepted submission of the product for review, the companies said “with the patient’s consent, this information could be shared with their healthcare professional team and selected family and friends, with the goal of allowing physicians to be more informed in making treatment decisions that are specific to the patient’s needs.”

While it’s the first time the FDA has approved such a pill, various specialty pharmacies and hospitals in the U.S. have previously “packaged” various drugs and sensors. But the federal endorsement increases the likelihood that insurers will eventually pay for the technology.

Drugmakers frequently reformulate their drugs to extend their patent life and to justify raising prices. For instance, Otsuka already sells a long-acting injectable version of Abilify intended to last for one month. The patent on the original Abilify pill expired in 2015.

The Japanese drugmaker has not said how it will price the digital pill. Proteus Digital Health, based in Redwood City California, makes the sensor.

Copyright 2020 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Top Videos

USF's food pantry helps fight food insecurities amid pandemic

Thumbnail for the video titled "USF's food pantry helps fight food insecurities amid pandemic"

1 dead, 2 injured in Lakeland crash

Thumbnail for the video titled "1 dead, 2 injured in Lakeland crash"

Monday Morning Forecast

Thumbnail for the video titled "Monday Morning Forecast"

Two cruise ships with Floridians board stuck at sea with deceased and sick passengers

Thumbnail for the video titled "Two cruise ships with Floridians board stuck at sea with deceased and sick passengers"

Gov. DeSantis addresses cruise ships looking to dock in Florida

Thumbnail for the video titled "Gov. DeSantis addresses cruise ships looking to dock in Florida"

Trump says he will speak with DeSantis about cruise ships

Thumbnail for the video titled "Trump says he will speak with DeSantis about cruise ships"

What money is out there for struggling small businesses?

Thumbnail for the video titled "What money is out there for struggling small businesses?"

Coronavirus test results delayed up to 14 days in Florida

Thumbnail for the video titled "Coronavirus test results delayed up to 14 days in Florida"

Better Call Behnken helps Port Richey woman get assurance her power won't be disconnected

Thumbnail for the video titled "Better Call Behnken helps Port Richey woman get assurance her power won't be disconnected"

strike teams answer coronavirus calls

Thumbnail for the video titled "strike teams answer coronavirus calls"

a Clearwater businessman is switching his focus from producing water heaters to producing face masks

Thumbnail for the video titled "a Clearwater businessman is switching his focus from producing water heaters to producing face masks"
More Local News

Trending Stories

get the app

News App

Weather App

Don't Miss

More Don't Miss